United States Recombinant vaccines Industry 2016 Market Research Report

June 2016 | 135 pages | ID: U3DC7CABE11EN
QYResearch

Abstracts

The United States Recombinant vaccines Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Recombinant vaccines industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant vaccines market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant vaccines industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 152 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Contents

1 INDUSTRY OVERVIEW

1.1 Definition and Specifications of Recombinant vaccines
  1.1.1 Definition of Recombinant vaccines
  1.1.2 Specifications of Recombinant vaccines
1.2 Classification of Recombinant vaccines
1.3 Applications of Recombinant vaccines
1.4 Industry Chain Structure of Recombinant vaccines
1.5 Industry Overview of Recombinant vaccines
1.6 Industry Policy Analysis of Recombinant vaccines
1.7 Industry News Analysis of Recombinant vaccines

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RECOMBINANT VACCINES

2.1 Bill of Materials (BOM) of Recombinant vaccines
2.2 BOM Price Analysis of Recombinant vaccines
2.3 Labor Cost Analysis of Recombinant vaccines
2.4 Depreciation Cost Analysis of Recombinant vaccines
2.5 Manufacturing Cost Structure Analysis of Recombinant vaccines
2.6 Manufacturing Process Analysis of Recombinant vaccines
2.7 United States Price, Cost and Gross of Recombinant vaccines 2011-2016

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Recombinant vaccines Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Recombinant vaccines Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Recombinant vaccines Key Manufacturers in 2015

4 PRODUCTION ANALYSIS OF RECOMBINANT VACCINES BY REGIONS, TYPE, AND APPLICATIONS

4.1 United States Production of Recombinant vaccines by Regions 2011-2016
4.2 United States Production of Recombinant vaccines by Type 2011-2016
4.3 United States Sales of Recombinant vaccines by Applications 2011-2016
4.4 Price Analysis of United States Recombinant vaccines Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Recombinant vaccines 2011-2016

5 CONSUMPTION VOLUME AND CONSUMPTION VALUE ANALYSIS OF RECOMBINANT VACCINES BY REGIONS

5.1 United States Consumption Volume of Recombinant vaccines by Regions 2011-2016
5.2 United States Consumption Value of Recombinant vaccines by Regions 2011-2016
5.3 United States Consumption Price Analysis of Recombinant vaccines by Regions 2011-2016

6 ANALYSIS OF RECOMBINANT VACCINES PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Recombinant vaccines 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Recombinant vaccines 2014-2015
6.3 Sales Overview of Recombinant vaccines 2011-2016
6.4 Supply, Consumption and Gap of Recombinant vaccines 2011-2016
6.5 Import, Export and Consumption of Recombinant vaccines 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Recombinant vaccines 2011-2016

7 ANALYSIS OF RECOMBINANT VACCINES INDUSTRY KEY MANUFACTURERS

7.1 GSK
  7.1.1 Company Profile
  7.1.2 Product Picture and Specifications
    7.1.2.1 Type I
    7.1.2.2 Type II
    7.1.2.3 Type III
  7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.1.4 Contact Information
7.2 Merck
  7.2.1 Company Profile
  7.2.2 Product Picture and Specifications
    7.2.2.1 Type I
    7.2.2.2 Type II
    7.2.2.3 Type III
  7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.2.4 Contact Information
7.3 Novartis
  7.3.1 Company Profile
  7.3.2 Product Picture and Specifications
    7.3.2.1 Type I
    7.3.2.2 Type II
    7.3.2.3 Type III
  7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.3.4 Contact Information
7.4 Pfizer
  7.4.1 Company Profile
  7.4.2 Product Picture and Specifications
    7.4.2.1 Type I
    7.4.2.2 Type II
    7.4.2.3 Type III
  7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.4.4 Contact Information
7.5 Sanofi
  7.5.1 Company Profile
  7.5.2 Product Picture and Specifications
    7.5.2.1 Type I
    7.5.2.2 Type II
    7.5.2.3 Type III
  7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.5.4 Contact Information
7.6 Bayer
  7.6.1 Company Profile
  7.6.2 Product Picture and Specifications
    7.6.2.1 Type I
    7.6.2.2 Type II
    7.6.2.3 Type III
  7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.6.4 Contact Information
7.7 Zoetis
  7.7.1 Company Profile
  7.7.2 Product Picture and Specifications
    7.7.2.1 Type I
    7.7.2.2 Type II
    7.7.2.3 Type III
  7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.7.4 Contact Information
7.8 AstraZeneca
  7.8.1 Company Profile
  7.8.2 Product Picture and Specifications
    7.8.2.1 Type I
    7.8.2.2 Type II
    7.8.2.3 Type III
  7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.8.4 Contact Information
7.9 Johnson & Johnson
  7.9.1 Company Profile
  7.9.2 Product Picture and Specifications
    7.9.2.1 Type I
    7.9.2.2 Type II
    7.9.2.3 Type III
  7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.9.4 Contact Information
7.10 Boehringer Ingelheim
  7.10.1 Company Profile
  7.10.2 Product Picture and Specifications
    7.10.2.1 Type I
    7.10.2.2 Type II
    7.10.2.3 Type III
  7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.10.4 Contact Information
7.11 CSL
  7.11.1 Company Profile
  7.11.2 Product Picture and Specifications
    7.11.2.1 Type I
    7.11.2.2 Type II
    7.11.2.3 Type III
  7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
  7.11.4 Contact Information

8 PRICE AND GROSS MARGIN ANALYSIS

8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Recombinant vaccines Product Types
8.5 Market Share Analysis of Different Recombinant vaccines Price Levels
8.6 Gross Margin Analysis of Different Recombinant vaccines Applications

9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF RECOMBINANT VACCINES

9.1 Marketing Channels Status of Recombinant vaccines
9.2 Traders or Distributors of Recombinant vaccines with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Recombinant vaccines
9.4 United States Import, Export and Trade Analysis of Recombinant vaccines

10 DEVELOPMENT TREND OF RECOMBINANT VACCINES INDUSTRY 2016-2021

10.1 Capacity and Production Overview of Recombinant vaccines 2016-2021
10.2 Production Market Share by Product Types of Recombinant vaccines 2016-2021
10.3 Sales and Sales Revenue Overview of Recombinant vaccines 2016-2021
10.4 United States Sales of Recombinant vaccines by Applications 2016-2021
10.5 Import, Export and Consumption of Recombinant vaccines 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Recombinant vaccines 2016-2021

11 INDUSTRY CHAIN SUPPLIERS OF RECOMBINANT VACCINES WITH CONTACT INFORMATION

11.1 Major Raw Materials Suppliers of Recombinant vaccines with Contact Information
11.2 Manufacturing Equipment Suppliers of Recombinant vaccines with Contact Information
11.3 Major Players of Recombinant vaccines with Contact Information
11.4 Key Consumers of Recombinant vaccines with Contact Information
11.5 Supply Chain Relationship Analysis of Recombinant vaccines

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF RECOMBINANT VACCINES

12.1 New Project SWOT Analysis of Recombinant vaccines
12.2 New Project Investment Feasibility Analysis of Recombinant vaccines

13 CONCLUSION OF THE UNITED STATES RECOMBINANT VACCINES INDUSTRY 2016 MARKET RESEARCH REPORT

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant vaccines
Table Product Specifications of Recombinant vaccines
Table Classification of Recombinant vaccines
Figure United States Sales Market Share of Recombinant vaccines by Product Types in 2015
Table Applications of Recombinant vaccines
Figure United States Sales Market Share of Recombinant vaccines by Applications in 2015
Figure Industry Chain Structure of Recombinant vaccines
Table United States Industry Overview of Recombinant vaccines
Table Industry Policy of Recombinant vaccines
Table Industry News List of Recombinant vaccines
Table Bill of Materials (BOM) of Recombinant vaccines
Table Bill of Materials (BOM) Price of Recombinant vaccines
Table Labor Cost of Recombinant vaccines
Table Depreciation Cost of Recombinant vaccines
Table Manufacturing Cost Structure Analysis of Recombinant vaccines in 2015
Figure Manufacturing Process Analysis of Recombinant vaccines
Table United States Price Analysis of Recombinant vaccines 2011-2016 (USD/mL)
Table United States Cost Analysis of Recombinant vaccines 2011-2016 (USD/mL)
Table United States Gross Analysis of Recombinant vaccines 2011-2016
Table Capacity (mL) and Commercial Production Date of United States Recombinant vaccines Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Recombinant vaccines Manufacturers in 2015
Table R&D Status and Technology Source of United States Recombinant vaccines Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Recombinant vaccines Key Manufacturers in 2015
Table United States Production of Recombinant vaccines by Regions 2011-2016 (mL)
Table United States Production Market Share of Recombinant vaccines by Regions 2011-2016
Figure United States Production Market Share of Recombinant vaccines by Regions in 2014
Figure United States Production Market Share of Recombinant vaccines by Regions in 2015
Table United States Production of Recombinant vaccines by Types in 2011-2016 (mL)
Table United States Production Market Share of Recombinant vaccines by Type in 2011-2016
Figure United States Production Market Share of Recombinant vaccines by Type in 2014
Figure United States Production Market Share of Recombinant vaccines by Type in 2015
Table United States Sales of Recombinant vaccines by Applications 2011-2016 (mL)
Table United States Production Market Share of Recombinant vaccines by Applications 2011-2016
Figure United States Production Market Share of Recombinant vaccines by Applications in 2014
Figure United States Production Market Share of Recombinant vaccines by Applications in 2015
Table Price Comparison of United States Recombinant vaccines Key Manufacturers in 2015 (USD/mL)
Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Recombinant vaccines 2011-2016
Table United States Consumption Volume of Recombinant vaccines by Regions 2011-2016 (mL)
Table United States Consumption Volume Market Share of Recombinant vaccines by Regions 2011-2016
Figure United States Consumption Volume Market Share of Recombinant vaccines by Regions in 2014
Figure United States Consumption Volume Market Share of Recombinant vaccines by Regions in 2015
Table United States Consumption Value of Recombinant vaccines by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Recombinant vaccines by Regions 2011-2016
Figure United States Consumption Value Market Share of Recombinant vaccines by Regions in 2014
Figure United States Consumption Value Market Share of Recombinant vaccines by Regions in 2015
Table Consumption Price of Recombinant vaccines by Regions 2011-2016 (USD/mL)
Table United States and Major Manufacturers Capacity of Recombinant vaccines 2011-2016 (mL)
Table United States Capacity Market Share of Major Recombinant vaccines Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Recombinant vaccines 2011-2016 (mL)
Table United States Production Market Share of Major Recombinant vaccines Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Recombinant vaccines 2011-2016 (mL)
Table United States Sales Market Share of Major Recombinant vaccines Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Recombinant vaccines 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Recombinant vaccines Manufacturers 2011-2016
Figure United States Capacity (mL), Production (mL) and Growth Rate of Recombinant vaccines 2011-2016
Figure United States Capacity Utilization Rate of Recombinant vaccines 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Recombinant vaccines 2011-2016
Figure United States Production Market Share of Major Recombinant vaccines Manufacturers in 2014
Figure United States Production Market Share of Major Recombinant vaccines Manufacturers in 2015
Figure United States Sales Market Share of Major Recombinant vaccines Manufacturers in 2014
Figure United States Sales Market Share of Major Recombinant vaccines Manufacturers in 2015
Figure United States Sales (mL) and Growth Rate of Recombinant vaccines 2011-2016
Table United States Supply, Consumption and Gap of Recombinant vaccines 2011-2016 (mL)
Table United States Import, Export and Consumption of Recombinant vaccines 2011-2016 (mL)
Table Price of United States Recombinant vaccines Major Manufacturers 2011-2016 (USD/mL)
Table Gross Margin of United States Recombinant vaccines Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Recombinant vaccines 2011-2016 (M USD)
Table United States Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Revenue (M USD) and Gross Margin of Recombinant vaccines 2011-2016
Table GSK Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of GSK
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of GSK 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of GSK 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of GSK 2011-2016
Table GSK Recombinant vaccines SWOT Analysis
Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of Merck
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Merck 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of Merck 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of Merck 2011-2016
Table Merck Recombinant vaccines SWOT Analysis
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of Novartis
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Novartis 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of Novartis 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of Novartis 2011-2016
Table Novartis Recombinant vaccines SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of Pfizer
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of Pfizer 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of Pfizer 2011-2016
Table Pfizer Recombinant vaccines SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of Sanofi
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Sanofi 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of Sanofi 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of Sanofi 2011-2016
Table Sanofi Recombinant vaccines SWOT Analysis
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of Bayer
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Bayer 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of Bayer 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of Bayer 2011-2016
Table Bayer Recombinant vaccines SWOT Analysis
Table Zoetis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of Zoetis
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Zoetis 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of Zoetis 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of Zoetis 2011-2016
Table Zoetis Recombinant vaccines SWOT Analysis
Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of AstraZeneca
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of AstraZeneca 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of AstraZeneca 2011-2016
Table AstraZeneca Recombinant vaccines SWOT Analysis
Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of Johnson & Johnson
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of Johnson & Johnson 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of Johnson & Johnson 2011-2016
Table Johnson & Johnson Recombinant vaccines SWOT Analysis
Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of Boehringer Ingelheim
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of Boehringer Ingelheim 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of Boehringer Ingelheim 2011-2016
Table Boehringer Ingelheim Recombinant vaccines SWOT Analysis
Table CSL Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant vaccines Picture and Specifications of CSL
Table Recombinant vaccines Capacity (mL), Production (mL), Price (USD/mL), Cost (USD/mL), Gross (USD/mL), Revenue (M USD) and Gross Margin of CSL 2011-2016
Figure Recombinant vaccines Capacity (mL), Production (mL) and Growth Rate of CSL 2011-2016
Figure Recombinant vaccines Production (mL) and United States Market Share of CSL 2011-2016
Table CSL Recombinant vaccines SWOT Analysis
Table Recombinant vaccines Price by Regions 2011-2016
Table Recombinant vaccines Price by Product Types 2011-2016
Table Recombinant vaccines Price by Companies 2011-2016
Table Recombinant vaccines Gross Margin by Companies 2011-2016
Table Price Comparison of Recombinant vaccines by Regions 2011-2016 (USD/mL)
Table Price of Different Recombinant vaccines Product Types (USD/mL)
Table Market Share of Different Recombinant vaccines Price Level
Table Gross Margin of Different Recombinant vaccines Applications
Table Marketing Channels Status of Recombinant vaccines
Table Traders or Distributors of Recombinant vaccines with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Recombinant vaccines (USD/mL) in 2015
Table United States Import, Export, and Trade of Recombinant vaccines (mL)
Figure United States Capacity (mL), Production (mL) and Growth Rate of Recombinant vaccines 2016-2021
Figure United States Capacity Utilization Rate of Recombinant vaccines 2016-2021
Table United States Recombinant vaccines Production by Type 2016-2021 (mL)
Table United States Recombinant vaccines Production Market Share by Type 2016-2021
Figure United States Production Market Share of Recombinant vaccines by Type in 2021
Figure United States Sales (mL) and Growth Rate of Recombinant vaccines 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Recombinant vaccines 2016-2021
Figure United States Sales of Recombinant vaccines by Applications 2016-2021 (mL)
Table United States Production Market Share of Recombinant vaccines by Applications 2016-2021
Figure United States Production Market Share of Recombinant vaccines by Applications in 2021
Table United States Production, Import, Export and Consumption of Recombinant vaccines 2016-2021 (mL)
Table United States Production (mL), Price (USD/mL), Cost (USD/mL), Revenue (M USD) and Gross Margin of Recombinant vaccines 2016-2021
Table Major Raw Materials Suppliers of Recombinant vaccines with Contact Information
Table Manufacturing Equipment Suppliers of Recombinant vaccines with Contact Information
Table Major Players of Recombinant vaccines with Contact Information
Table Key Consumers of Recombinant vaccines with Contact Information
Table Supply Chain Relationship Analysis of Recombinant vaccines
Table New Project SWOT Analysis of Recombinant vaccines
Table New Project Investment Feasibility Analysis of Recombinant vaccines
Table Part of Interviewees Record List